Suppr超能文献

类风湿关节炎患者的良性、非典型和恶性淋巴增殖性疾病。

Benign, atypical and malignant lymphoproliferative disorders in rheumatoid arthritis patients.

作者信息

Kojima M, Motoori T, Nakamura S

机构信息

Department of Pathology and Clinical Laboratories, Gunma Cancer Center Hospital, 617-1, Takabayashinishi-cho, 373-8550 Ohta, Japan.

出版信息

Biomed Pharmacother. 2006 Dec;60(10):663-72. doi: 10.1016/j.biopha.2006.09.004. Epub 2006 Oct 19.

Abstract

Lymphadenopathy, which may be associated with systemic symptoms, is frequently associated with rheumatoid arthritis (RA). Reactive non-neoplastic tissue comprises the majority of the lymph node lesions. However, several cohort studies have demonstrated that RA has an increased risk of non-Hodgkin's lymphomas (NHLs). Since the early 1990s, an atypical or malignant lymphoproliferative disorders (LPD) in patients immunosupressed with methtorexate (MTX) therapy for RA has been emphasized, namely MTX-associated LPDs. Epstein-Barr virus (EBV) has received attention in connection with the etiology of RA. The present review describes the clinicopathologic and immunohistochemical findings of reactive, atypical and malignant LPDs associated with RA along with the presence or absence of EBV in LPDs using the in situ hybridization (ISH) method. The majority of reactive lymph node lesions exhibit reactive follicular hyperplasia with interfollicular polyclonal plasmacytosis. Atypical LPDs rarely appears in RA patients. However, these cases occasionally pose difficult problems in the differential diagnosis from malignant lymphomas associated with RA or atypical and malignant LPDs showing RA-like clinicopathological findings. Clinicopathologically, three types of atypical LPDs have delineated, i.e. (i) resembling multicentric Castleman's disease (MCD); (ii) atypical paracortical hyperplasia with lymphoid follicles (APHLF) and; (iii) atypical lymphoplasmacytic immunoblastic proliferation. Malignant lymphoma associated with RA is characterized by; (i) predominance of elderly cases; (ii) usually female predominance, reflecting the sex ratio of RA; (iii) longstanding history of RA; (iv) relatively frequent advanced stage of disease; (v) majority of the patients had the B-cell phenotype; and (vi) an increased frequency of diffuse large B-cell lymphoma (DLBCL) in RA. It is unlikely that EBV is the causative agent of either reactive or atypical LPD. Among malignant lymphomas, EBV-associated lymphoma comprised only a small fraction of all NHLs in the general RA patient population.

摘要

淋巴结病可能伴有全身症状,常与类风湿关节炎(RA)相关。反应性非肿瘤组织构成了大多数淋巴结病变。然而,多项队列研究表明,RA患者患非霍奇金淋巴瘤(NHL)的风险增加。自20世纪90年代初以来,对于接受甲氨蝶呤(MTX)治疗的RA免疫抑制患者中出现的非典型或恶性淋巴增殖性疾病(LPD),即MTX相关LPD,已受到关注。爱泼斯坦-巴尔病毒(EBV)在RA病因学方面受到了关注。本综述描述了与RA相关的反应性、非典型和恶性LPD的临床病理及免疫组化结果,以及使用原位杂交(ISH)方法检测LPD中EBV的有无。大多数反应性淋巴结病变表现为反应性滤泡增生伴滤泡间多克隆浆细胞增多。非典型LPD在RA患者中很少出现。然而,这些病例偶尔在与RA相关的恶性淋巴瘤或表现出RA样临床病理特征的非典型和恶性LPD的鉴别诊断中带来难题。临床病理上,已明确三种非典型LPD类型,即:(i)类似多中心Castleman病(MCD);(ii)伴有淋巴滤泡的非典型副皮质增生(APHLF);(iii)非典型淋巴浆细胞免疫母细胞增殖。与RA相关的恶性淋巴瘤的特征为:(i)老年病例占优势;(ii)通常女性占优势,反映了RA的性别比例;(iii)RA病史长;(iv)疾病晚期相对常见;(v)大多数患者为B细胞表型;(vi)RA中弥漫性大B细胞淋巴瘤(DLBCL)的发生率增加。EBV不太可能是反应性或非典型LPD的致病因素。在恶性淋巴瘤中,EBV相关淋巴瘤在一般RA患者群体的所有NHL中仅占一小部分。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验